Market Cap 152.56M
Revenue (ttm) 440,000.00
Net Income (ttm) -35.13M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -7,984.09%
Debt to Equity Ratio 0.00
Volume 363,300
Avg Vol 225,424
Day's Range N/A - N/A
Shares Out 13.15M
Stochastic %K 78%
Beta 0.88
Analysts Strong Sell
Price Target $32.00

Company Profile

Avalo Therapeutics, Inc., a clinical stage biotechnology company, focuses on the development of therapies for the treatment of immune dysregulation in the Unites States. Its lead asset includes AVTX-009, a humanized monoclonal antibody that binds to interleukin-1ß, which is in phase 2 clinical trial to treat inflammatory diseases. The company was formerly known as Cerecor Inc. and changed its name to Avalo Therapeutics, Inc. in August 2021. Avalo Therapeutics, Inc. was incorporated in 2011 and i...

Industry: Biotechnology
Sector: Healthcare
Phone: 410 522 8707
Address:
540 Gaither Road, Suite 400, Rockville, United States
Trapjaw
Trapjaw Sep. 8 at 9:31 AM
$AVTX today the next
0 · Reply
WallStVisions
WallStVisions Sep. 7 at 8:34 PM
SKYQ is not some no-revenue fluff. → Over $19M in trailing revenue → Building tokenized infrastructure in the energy sector → Short-term RSI reversal brewing → Trading at a discount vs every clean tech peer Chart looks like it’s about to get loud. $VEEE $PHUN $TRKA $AVTX
0 · Reply
SmartOptionsAl
SmartOptionsAl Sep. 6 at 12:58 PM
$AVTX – Avalo Therapeutics is advancing its anti‑IL‑18 antibody AVTX‑802 in Phase 2 trials for autoimmune diseases. It recently closed a $45M financing to fund operations into 2026 and regained Nasdaq compliance.
0 · Reply
StockScanners
StockScanners Sep. 6 at 11:39 AM
$AVTX reached 12.41
1 · Reply
superOTLK
superOTLK Sep. 6 at 3:01 AM
$AVTX what is the driver behind this stock ? speculation ? there is no revenue , $OTLK has revenue but less than a $1 and hit so badly on 27 August 2025.
3 · Reply
Trapjaw
Trapjaw Sep. 5 at 9:42 PM
0 · Reply
topstockalerts
topstockalerts Sep. 5 at 4:47 PM
$AVTX not bad today.. 🙌
0 · Reply
Trapjaw
Trapjaw Sep. 5 at 4:10 PM
$AVTX we should be tren
0 · Reply
SilentJoker34
SilentJoker34 Sep. 5 at 4:06 PM
0 · Reply
Djohn2012
Djohn2012 Sep. 5 at 3:48 PM
$AVTX Have a look at bro $TVTX
0 · Reply
Latest News on AVTX
Avalo Reports 2024 Financial Results and Recent Business Updates

Mar 20, 2025, 7:00 AM EDT - 6 months ago

Avalo Reports 2024 Financial Results and Recent Business Updates


Avalo Therapeutics to Present at Upcoming Investor Conferences

Nov 11, 2024, 7:00 AM EST - 10 months ago

Avalo Therapeutics to Present at Upcoming Investor Conferences


Avalo Therapeutics Announces 1-for-240 Reverse Stock Split

Dec 27, 2023, 7:00 AM EST - 1 year ago

Avalo Therapeutics Announces 1-for-240 Reverse Stock Split


Avalo Completes Divestiture of AVTX-800 Series

Oct 31, 2023, 7:00 AM EDT - 2 years ago

Avalo Completes Divestiture of AVTX-800 Series


Top trending biotech stocks: ANVS, MTNB, AVTX, TPST

Oct 12, 2023, 11:26 AM EDT - 2 years ago

Top trending biotech stocks: ANVS, MTNB, AVTX, TPST

ANVS MTNB TPST


Avalo Enters into Agreement to Divest AVTX-800 Series

Sep 12, 2023, 7:00 AM EDT - 2 years ago

Avalo Enters into Agreement to Divest AVTX-800 Series


Avalo to Participate in SVB Securities Therapeutics Forum

Jul 6, 2023, 4:01 PM EDT - 2 years ago

Avalo to Participate in SVB Securities Therapeutics Forum


Avalo to Present at the Jefferies Healthcare Conference

Jun 1, 2023, 7:00 AM EDT - 2 years ago

Avalo to Present at the Jefferies Healthcare Conference


Avalo to Present at ATS 2023 Respiratory Innovation Summit

May 15, 2023, 7:00 AM EDT - 2 years ago

Avalo to Present at ATS 2023 Respiratory Innovation Summit


Avalo Therapeutics Announces Board Changes

Aug 11, 2022, 4:01 PM EDT - 3 years ago

Avalo Therapeutics Announces Board Changes


Trapjaw
Trapjaw Sep. 8 at 9:31 AM
$AVTX today the next
0 · Reply
WallStVisions
WallStVisions Sep. 7 at 8:34 PM
SKYQ is not some no-revenue fluff. → Over $19M in trailing revenue → Building tokenized infrastructure in the energy sector → Short-term RSI reversal brewing → Trading at a discount vs every clean tech peer Chart looks like it’s about to get loud. $VEEE $PHUN $TRKA $AVTX
0 · Reply
SmartOptionsAl
SmartOptionsAl Sep. 6 at 12:58 PM
$AVTX – Avalo Therapeutics is advancing its anti‑IL‑18 antibody AVTX‑802 in Phase 2 trials for autoimmune diseases. It recently closed a $45M financing to fund operations into 2026 and regained Nasdaq compliance.
0 · Reply
StockScanners
StockScanners Sep. 6 at 11:39 AM
$AVTX reached 12.41
1 · Reply
superOTLK
superOTLK Sep. 6 at 3:01 AM
$AVTX what is the driver behind this stock ? speculation ? there is no revenue , $OTLK has revenue but less than a $1 and hit so badly on 27 August 2025.
3 · Reply
Trapjaw
Trapjaw Sep. 5 at 9:42 PM
0 · Reply
topstockalerts
topstockalerts Sep. 5 at 4:47 PM
$AVTX not bad today.. 🙌
0 · Reply
Trapjaw
Trapjaw Sep. 5 at 4:10 PM
$AVTX we should be tren
0 · Reply
SilentJoker34
SilentJoker34 Sep. 5 at 4:06 PM
0 · Reply
Djohn2012
Djohn2012 Sep. 5 at 3:48 PM
$AVTX Have a look at bro $TVTX
0 · Reply
CAPITALWHISPERER
CAPITALWHISPERER Sep. 5 at 3:44 PM
$MSPR $5 coming. $1.6B assets. nano float 300k. $35 last run. boom like $INHD and $AVTX
0 · Reply
SilentJoker34
SilentJoker34 Sep. 5 at 3:26 PM
$OTLK Serious question 🤔 How TF is $AVTX worth $11 with no drug no sales and no revenue.. Buuut $OTLK is $1 with an approved drug in EU/UK +sales +revenue Make it make sense....!
3 · Reply
Trapjaw
Trapjaw Sep. 5 at 3:04 PM
$AVTX ist this the moa ass i have been wainting for🤣 Pls $GME Do the same that i can retire
0 · Reply
Baba200TradeBot
Baba200TradeBot Sep. 5 at 3:00 PM
lowfloatreport.com/ - $AVTX ⬆️ Classic Gap-Up-Stay-Up on this biotech: it leapt +5.31% over yesterday’s $10.16 close, opened $10.70, and is now printing $11.28 (+11.02%), holding above the pre-market high $10.99 and pushing HOD $11.25—buyers are clearly in control while shorts (only 0.86% of the 10.5 M float, 0.45 d to cover) have minimal ammo, making every dip feel like a gift. 📈 Volume is the tell: 115 K shares may sound light, but against that tiny float it’s already 1.1 % float turnover and 2.17 × average velocity; extrapolated through the session the float could rotate >6 % before lunch, plenty for VWAP algos and momentum desks to cannon-ball higher as each test of the $0.81 ATR band gets soaked up.
0 · Reply
Trapjaw
Trapjaw Sep. 5 at 2:59 PM
0 · Reply
BioTechHealthX
BioTechHealthX Sep. 5 at 2:10 PM
$AVTX Avalo’s stock has jumped 45% in six months. With $113M cash, Buy ratings, and a $30 average target, analysts project nearly 195% more upside. https://biotechhealthx.com/biotech-news/avalo-therapeutics-avtx-surges-45-in-6-months/
1 · Reply
Trapjaw
Trapjaw Sep. 5 at 1:29 PM
0 · Reply
SilentJoker34
SilentJoker34 Sep. 5 at 1:16 PM
0 · Reply
Trapjaw
Trapjaw Sep. 5 at 1:08 PM
$AVTX interesting day ahead
0 · Reply
Trapjaw
Trapjaw Sep. 5 at 1:07 PM
$AVTX https://www.google.com/amp/s/m.investing.com/news/analyst-ratings/cowen-initiates-avalo-therapeutics-stock-with-buy-rating-93CH-4226305%3fampMode=1
0 · Reply
Trapjaw
Trapjaw Sep. 5 at 1:06 PM
$AVTX https://www.tipranks.com/news/ratings/buy-rating-for-avalo-therapeutics-driven-by-promising-avtx-009-development-and-market-potential-ratings?utm_source=webullapp.com&utm_medium=referral
0 · Reply
Trapjaw
Trapjaw Sep. 5 at 1:05 PM
$AVTX https://www.tipranks.com/news/the-fly/avalo-therapeutics-initiated-with-a-buy-at-td-cowen-thefly?utm_source=webullapp.com&utm_medium=referral
0 · Reply